Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines

Lea S. Flocke(University of Vienna), Bernhard K. Keppler(University of Vienna)

Investigational New Drugs

March 18, 2016

10.1007/s10637-016-0337-8

Cited by 121

Related Papers

Triapine and a More Potent Dimethyl Derivative Induce Endoplasmic Reticulum Stress in Cancer Cells

|Molecular Pharmacology|2014|39

Influence of reducing agents on the cytotoxic activity of platinum(<scp>iv</scp>) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines

|Metallomics|2015|38

Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors

|JBIC Journal of Biological Inorganic Chemistry|2020|19

Anticancer Tungstenocenes with a Diverse Set of (O,O–), (O,S–) and (O,N–) Chelates—A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models

|Pharmaceutics|2023|2